Protagen AG Appoints New Board Members
Protagen AG appoints two new members for the Executive Board.
Dr. Peter Schulz-Knappe, former CSO at Proteome Sciences plc., started his new position with the beginning of the year. He will take over operational responsibility for the Business Unit Diagnostics. At the same time, Martin Blüggel, cofounder and COO, joins the board and will manage the Business Unit Protein Services.
Furthermore, Dr. Thomas Schweins, Member of the Executive Committee of Qiagen and Vice President Marketing & Strategy, completes the Supervisory Board. Dr. Schweins, a trained biochemist, is a professional expert in the global diagnostic businesses. Before joining Qiagen, he held positions in the Pharma/Health Care Unit of Boston Consulting Group, and as project manager at Hoechst AG/Aventis SA.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.